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ABSTRACT The HIV-1 Rev protein is a nuclear export factor for unspliced and incom-
pletely spliced HIV-1 RNAs. Without Rev, these intron-retaining RNAs are trapped in
the nucleus. A genome-wide screen identified nine proteins of the spliceosome, which
all enhanced expression from the HIV-1 unspliced RNA after CRISPR/Cas knockdown.
Depletion of DHX38, WDR70, and four proteins of the Prp19-associated complex (ISY1,
BUD31, XAB2, and CRNKL1) resulted in a more than 20-fold enhancement of unspliced
HIV-1 RNA levels in the cytoplasm. Targeting of CRNKL1, DHX38, and BUD31 affected
nuclear export efficiencies of the HIV-1 unspliced RNA to a much larger extent than
splicing. Transcriptomic analyses further revealed that CRNKL1 also suppresses cyto-
plasmic levels of a subset of cellular mRNAs, including some with selectively retained
introns. Thus, CRNKL1-dependent nuclear retention is a novel cellular mechanism for
the regulation of cytoplasmic levels of intron-retaining HIV-1 mRNAs, which HIV-1 may
have harnessed to direct its complex splicing pattern.
IMPORTANCE To regulate its complex splicing pattern, HIV-1 uses the adaptor protein
Rev to shuttle unspliced or partially spliced mRNA from the nucleus to the cyto-
plasm. In the absence of Rev, these RNAs are retained in the nucleus, but it is
unclear why. Here we identify cellular proteins whose depletion enhances cytoplas-
mic levels of the HIV-1 unspliced RNA. Depletion of one of them, CRNKL1, also
increases cytoplasmic levels of a subset of intron-retaining cellular mRNA, sug-
gesting that CRNKL1-dependent nuclear retention may be a basic cellular mecha-
nism exploited by HIV-1.
KEYWORDS CRNKL1, RNA splicing, association, human immunodeficiency virus, intron-
retaining RNA, nuclear retention
Intron retention is increasingly recognized as a regulatory mechanism of gene expres-sion and diversification of the cellular proteome (1). Transcriptomic analyses indicate
that a large percentage of eukaryotic genes encode transcripts retaining introns (2, 3).
Intron-retaining transcripts may be trapped in the nucleus, leading to their degrada-
tion. Alternatively, specialized nuclear export pathways may enable certain intron-
retaining transcripts to reach the cytoplasm, where they can be translated or undergo
nonsense-mediated decay. Retroviruses use intron retention to encode multiple pro-
teins from one primary transcript. RNA secondary structures or cellular or viral adaptor
proteins link intron-retaining retroviral transcripts in the nucleus to the TAP/NXF1 or
the CRM-1 nuclear export factors (4), leading to the export of intron-retaining RNAs.
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While a number of studies have explored how nuclear retention can be overcome, the
factors mediating nuclear retention of intron-containing mRNAs are mostly unknown
but are likely linked to partial assembly of splicing complexes on intron-containing
RNA (5).
The first evidence for a regulated export and expression of intron-retaining RNAs in
mammalian cells was obtained in studies investigating the replication of human immu-
nodeficiency virus type 1 (HIV-1). Alternative splicing and intron retention leads to
three types of transcripts: fully spliced (FS) mRNAs, incompletely spliced (IS) mRNAs,
and the unspliced (US) genomic RNA (6). The process of viral gene expression is tempo-
rally regulated, resulting in early expression of regulatory proteins and late expression
of structural proteins (7–9). In the early phase, the US and IS transcripts are retained in
the nucleus and are subjected to the nuclear splicing or degradation machinery (10).
Only FS transcripts are transported to the cytoplasm via the default mRNA export path-
way, TAP/NXF1, leading to expression of Tat, Rev, and Nef proteins (11, 12). The regula-
tory proteins Tat and Rev are nuclear cytoplasmic shuttle proteins and regulate viral
gene expression. While Tat transactivates transcription by enhancing RNA elongation,
Rev fine-tunes posttranscriptional processes and acts as a switch to initiate the late
phase of the viral replication cycle (reviewed in references 13 and 14). It binds to the
Rev-responsive element (RRE), which is present in the HIV-1 US and IS transcripts but
not in the FS transcripts, and multimerizes on the RRE. The protein exporting factor
CRM1 and associated factors are recruited by the Rev-RRE complex, leading to the nu-
clear-cytoplasmic export of these two classes of RNA (15).
Nuclear retention of intron-retaining HIV-1 RNAs has been hypothesized to be due
to a number of mechanisms that are not mutually exclusive. One of them is the lack of
cis-acting elements necessary for access to the TAP/NXF1 nuclear export pathway. Cell
biological and virological studies have discovered that RNAs normally gain access to
the exportin NXF1 by two means: either by recruitment of the transcription-export
(TREX) complex via splicing (16) or by evolving particular regulatory sequences, e.g.,
the constitutive transport element (CTE) from type D retrovirus Mason-Pfizer monkey
virus (MPMV), which has direct binding activity to NXF1 (17). A second explanation is
the suboptimal splice sites of HIV that lead to the trapping of the intron-retaining
RNAs in the spliceosome and subsequent degradation (18, 19). In addition, multiple in-
hibitory sequences (INS) were identified in the retained introns (20–24). The presumed
inactivation of these inhibitory sequences by codon optimizing the AT-rich HIV-1
sequence abolished nuclear retention (25) independent of the presence or absence of
HIV-1 splice donor (SD) and splice acceptor (SA) sites (26, 27). Why AT-rich intron-con-
taining HIV-1 sequences, but not the codon-optimized variants, are retained remains
elusive. It has been reported that knockdown of the paraspeckle long-noncoding RNA
(lncRNA) NEAT1 could promote HIV Gag production through increased nucleocytoplas-
mic export of INS-containing RNAs, implicating the nuclear paraspeckles in the nuclear
retention of HIV US and IS RNAs (28). However, this has been questioned by a study
demonstrating that HIV-1 US RNA was not actually colocalized with paraspeckles (29),
despite that several paraspeckle proteins (PSF, Martin3, and RBM14) have been reported
to associate with HIV-1 INS elements and/or promote the Rev-dependent RNA export
(30–34, 98).
In addition to these viral determinants and lncRNA contributing to nuclear mRNA
retention, depletion of hnRNPA2/B1 has been shown to increase cytoplasmic levels of
HIV-1 genomic RNA, but this increase did not enhance Gag expression levels and the
precise mechanism remains unknown (35). With regard to nuclear retention of mRNA
in general, a cellular complex named pre-mRNA retention and splicing complex (RES)
has been identified in Saccharomyces cerevisiae (36). The RES is composed of Bud13,
Snu17p, and Pml1P, and inactivation of any of the genes encoding these proteins in
yeast reduces splicing of an intron with a weak 59 splice donor. In addition, Pml1P inac-
tivation enhanced expression of a pre-mRNA reporter construct without substantial
reduction of the spliced mRNA, suggesting a role of Pml1P and the RES in nuclear
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retention. More recently, BUD13 was identified to bind to the poorly spliced mRNA of
mammalian IRF7, a master regulator of the interferon response (37). Knockdown of
BUD13 specifically enhanced retention of intron 4 of IRF7 in stimulated cells, thus
reducing IRF7 protein levels and dampening the interferon response. However, intron-
containing IRF7 mRNA could not be detected in the cytoplasm (37), indicating addi-
tional nuclear trapping mechanisms or rapid cytoplasmic degradation of intron-con-
taining IRF7 mRNA. HIV-1 introns also differ from typical RES-dependent introns
(37–39) by their low GC content, challenging the hypothesis that HIV-1 splicing may be
regulated by the RES.
An alternative nuclear trapping mechanism could be a cellular quality control
mechanism for mRNAs located at the nuclear pore complex (NPC). Experimental or
stress-induced interference with this complex results in leakage of intron-retaining
mRNAs into the cytoplasm (40–43). This finding suggests that the NPC-associated qual-
ity control complex also has a role in nuclear retention of intron-containing mRNAs,
probably as a backup mechanism not influencing the initial splicing events. Here, we
identified cellular proteins involved in nuclear trapping of intron-retaining HIV-1
mRNAs by performing a genome-wide screen for cellular factors, whose depletion
resulted in enhanced expression from HIV-1 unspliced transcripts in the absence of its
export factor Rev. Furthermore, we examined the effect of identified cellular factors on
HIV US and FS RNA localization and expression. This revealed that CRNKL1 is a nuclear
retention factor of the HIV-1 unspliced RNA and a selective regulator of cytoplasmic
levels of a subset of intron-retaining cellular mRNAs.
RESULTS
Reporter cell lines for HIV-1 Rev-independent expression from the unspliced
RNA. The overall strategy to identify cellular proteins involved in the nuclear trapping
of intron-retaining HIV-1 mRNAs was to inactivate cellular genes by a genome-wide
lentiviral CRISPR-Cas knockout library and to select knockout cells that show enhanced
Gag expression from a proviral Rev-deficient HIV-1 reporter construct. To easily quan-
tify HIV Gag expression in living cells, the Gag open reading frame (ORF) was fused to
the blue fluorescent protein (BFP) gene. The rev gene was inactivated by two point
mutations, and the DsRed reporter gene was expressed in place of nef from a fully
spliced HIV-1 transcript in order to mark HIV-infected cells in the absence of Rev
(Fig. 1A). Since we aimed to establish stable cell clones containing such proviral re-
porter constructs, expression of pol, vif, vpr, and vpu was also blocked by point muta-
tions to avoid difficulties due to potential cytotoxic or cytostatic effects of these viral
proteins (44–46). The env gene was inactivated by a 4-bp deletion, resulting in a frame-
shift. Although this reporter construct, designated HIV-dual-GT encodes only the
Gag-BPF fusion protein, DsRed, and Tat (for sufficient transcriptional activation), all
known cis-acting sequences potentially interacting with cellular components should be
maintained.
To characterize the expression pattern of HIV-dual-GT, HEK293T cells were trans-
fected with plasmids containing HIV-dual-GT or a rev-deficient env deletion mutant of
HIV in the presence or absence of a Rev expression plasmid. Western blot analyses
revealed Rev-dependent expression of the Gag-BFP fusion protein (Fig. 1B). Flow cyto-
metric analysis of HEK293T cells transfected with HIV-dual-GT revealed a major DsRed-posi-
tive but BFP-negative cell population, which shifted to a double-positive population by
cotransfection of a Rev expression plasmid (Fig. 1C). DsRed expression seemed to decrease
in the presence of Rev, consistent with reduced splicing and consequently reduced gener-
ation of fully-spliced DsRed mRNA due to rapid export of unspliced transcripts (7).
To generate reporter cell lines harboring a properly integrated proviral DNA of HIV-
dual-GT, it was encapsidated and pseudotyped by cotransfection with HIV-gag-pol and
VSV-G expression plasmids. The Rev deficiency was also complemented by cotransfec-
tion of a Rev expression plasmid. Titers of the HIV-dual-GT vector were in the range of
5 105 transforming units (TU)/ml. Flow cytometric analysis of Jurkat cells transduced
with these VSV-G-pseudotyped HIV-dual-GT vector particles revealed a distinct
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FIG 1 Establishment of HIV-dual-GT reporter cell clones. (A) Map of the HIV-dual-GT proviral reporter construct. (B) Western blot analysis of lysates of
HEK293T cells transfected with HIV-dual-GT or HIV.r2e2 in the presence or absence of a Rev expression plasmid (pcRev) with antibodies to the p24 capsid
(Continued on next page)
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population of cells that were DsRed positive but BFP negative (Fig. 1D). Transient trans-
fection of this transduced bulk culture with a Rev expression plasmid shifted approxi-
mately 10% of the DsRed-positive population to a DsRed and BFP double-positive pop-
ulation. The magnitude of this effect was lower than in the cotransfection experiments
in 293T cells (Fig. 1C), consistent with the lower transfection efficiency for Jurkat cells.
To obtain more homogenous reporter cells, Jurkat cell clones containing HIV-dual-
GT were established by transducing Jurkat cells at a multiplicity of infection (MOI) of
0.1, followed by flow cytometric sorting of single DsRed-positive, BFP-negative cells
into wells of a 96-well plate (Fig. 1E). Two of the expanded DsRed-positive cell clones,
showing a rather homogenous population of DsRed-positive and BPF-negative cells
and designated J-dual#3 and J-dual#6, were transduced at an MOI of 2 with VSV-G-
peudotyped env deletion mutants of HIV containing or lacking a functional rev gene. In
the presence of a functional rev gene, the BFP fluorescence was strongly induced in
both reporter cell clones (Fig. 1F). Therefore, both clones were selected for the screen-
ing of cellular genes that suppress BFP expression from the HIV-dual-GT reporter virus.
Genome-wide screening for cellular factors suppressing expression from intron-
containing HIV-1 genomic RNA. Poor expression levels of HIV-1 structural genes in
the absence of Rev that can be overcome by modifying the codon usage suggest that
there is an active cellular suppressive mechanism acting on the level of the viral tran-
script. To identify cellular proteins necessary for this postulated suppressive mecha-
nism, we used a GeCKOv2 genome-wide CRISPR-Cas knockout library kindly provided
by the laboratory of Feng Zhang (47, 48). The plasmid library contains 122,411 different
single guide RNA (sgRNA) genes targeting 19,050 human genes (6 sgRNAs per gene)
and 1,864 sgRNA genes targeting microRNA (miRNA) genes (4 sgRNAs per miRNA
gene) and includes 1,000 nontargeting (NT) sgRNA genes. Cas9, sgRNA, and puromycin
resistance genes are expressed from a single lentiviral vector construct, lentiCRISPRv2.
After amplification of the plasmid library and confirmation of its diversity by next-gen-
eration sequencing (NGS; data not shown), a stock of a VSV-G-pseudotyped lentiviral
vector library was prepared by transient transfection of 293T cells and titrated on the
Jurkat reporter cell clones, J-dual#3 and J-dual#6, and parental Jurkat cells. All three
cell lines were then transduced with the lentiviral CRISPR library at an MOI of around 2.
Four days after transduction, the 0.01 to 0.02% DsRed-positive cells showing the high-
est BFP expression levels were sorted for NGS of the sgRNA genes delivered to these
cells by the lentiviral vector library. To be able to determine enrichment of sgRNA
genes enhancing Gag-BFP expression levels, the representation of each sgRNA gene
from nonselected Jurkat cells transduced with the lentiviral CRISPR library was also
determined. Selective enrichment of sgRNA sequences in sorted J-dual#3 and J-dual#6
cells compared to nonsorted Jurkat cells was then determined by MAGeCK, a computa-
tional tool developed for the analysis of CRISPR screens (49, 50). The calculated robust
ranking aggregation (RRA) score reflects enrichment of sgRNA sequences targeting the
same gene in the selected cells. The distribution of the RRA score for all targeted genes
is plotted in Fig. 2C, with the top 12 candidate genes highlighted. For 11 of these, at least
two different sgRNA sequences targeting the same gene were enriched in the selected
cells, arguing against confounding off-target effects of single sgRNA (Fig. 2D). The proba-
bility of false discovery of the top 12 candidate genes ranged from 0.0012 to 0.15.
Analyzing interaction of validated hits shows a network of pre-mRNA splicing
factors. Based on the enrichment of the individual sgRNAs targeting each of the top
12 candidate genes in the Gag-BFP-positive cells selected by flow cytometry (see Fig. S1
in the supplemental material), two sgRNA sequences were chosen for each of the candi-
date genes (Table S1A) for further validation. Gene-specific sgRNA sequences and a
FIG 1 Legend (Continued)
protein, a-tubulin, or Rev. (C) 293T cells transfected with HIV-dual-GT and pcRev or pcDNA3.1 were analyzed by flow cytometry for Gag-BFP and DsRed
expression. (D) Jurkat cells transduced with the HIV-dual-GT reporter vector (MOI, 0.3) and transiently transfected with pcRev or pcDNA control plasmid
were analyzed by flow cytometry. (E) Scheme for the generation of reporter cell clones. (F) HIV-dual-GT-transduced Jurkat reporter cell clones J-dual#3 and
J-dual#6 were superinfected with VSV-G-pseudotyped HIV-1 viruses differing only in the expression of Rev and analyzed by flow cytometry. All assays were
performed at least twice, and results of one representative experiment are shown.
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nontargeting sequence, named NT1, were cloned individually into the lentiCRISPRv2 vec-
tor plasmid. J-dual#3 and J-dual#6 reporter cells were then transduced with lentiviral
vector particles transferring these sgRNA sequences. Upregulation of BFP expression was
observed by flow cytometry for 10 of the 12 candidate genes. For nine of them, transfer
of both sgRNA sequences upregulated BFP expression in both reporter cell clones
(Fig. S2A). For DUS2 and ZNF221, the screening results could not be confirmed. Since long
half-lives of mRNAs and proteins may prolong the time from inactivation of the targeted
gene to the decline of protein levels, we continued to monitor the reporter cells trans-
duced with sgRNA genes targeting DUS2 and ZNF221 for up to 2weeks postinfection.
However, upregulation of Gag-BFP remained undetectable (data not shown). In addition,
we confirmed sufficient transduction rates by the lentiviral DUS2 and ZNF221 targeting
vectors, excluding the possibility that reduced lentiviral vector titers are responsible for
FIG 2 Genome-wide CRISPR/Cas screen. (A) Outline of screening strategy. (B) Flow cytometric analysis of J-dual#3 and J-dual#6 reporter cells without
transduction and 4 days after transduction by the GeCKO v2 lentiviral vector library (MOI, around 2) immediately prior to the sorting process. The total
number of events shown in the graph, total number of cells analyzed in the screen, and total numbers of cells sorted are indicated. (C) Enrichment analysis
for guide RNAs in transduced and selected J-dual#3 and J-dual#6 reporter cells compared to transduced but unselected Jurkat cells by the MAGeCK
program. The robust ranking aggregation (RRA) score reflects the enrichment of guide RNA targeting the same gene in cells selected from both reporter
cell clones. The distribution of the negative log10 of the RRA score for all targeted genes in alphabetical order on the x axis is shown, with the top 12
candidate genes highlighted. (D) Additional MAGeCK ranking parameters of the top 12 candidate genes. fdr, false discovery rate; # sgRNA, number of
enriched guide RNAs targeting the same gene.
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their failure to upregulate BFP expression (Fig. S2B). Despite this, the entire screening
approach was highly specific, showing a false discovery rate (FDR) of only 0.166.
A first hint of potential mechanisms by which inactivation of the identified cellular
genes could enhance Gag-BFP expression in the reporter cell lines was obtained by
searching for functional protein association networks between the identified genes
using the STRING online database (https://string-db.org/). Strikingly, 9 of the 10 con-
firmed hits are involved in pre-mRNA splicing (Fig. 3). Among them is ESS2/DGCR14,
for which no interactions with the other identified factors have been reported but
which is associated with U6 snRNA as well as U1 and U4 snRNAs (51). WDR70 is not
linked to splicing; however, it contains a WD40 repeat domain which is shared by a
number of splicing factors (52). The pre-mRNA splicing process includes two excision
steps catalyzed by a large and dynamic RNP machine. The confirmed hits DHX38,
DHX8, SLU7, and DGCR14 are typical second-step factors. In contrast, XAB2, ISY1,
CRNKL1, CWC22, and BUD31 should be recruited at the first step, and intriguingly, all
belong to the nuclear Prp19-associated complex (53–56). This complex is involved in
diverse nuclear functions, such as DNA double-strand break (DSB) repair, transcrip-
tional elongation, and splicing (57). The core factor of the complex, PRPF19 (human
Prp19), however, was not identified in the screen. Consistently, targeting PRPF19 by
two sgRNAs in J-dual#3 did not affect Gag-BFP expression (Fig. S3A). Since most of the
confirmed hits are components of the spliceosome, we analyzed whether PRPF8, an
ATPase/helicase at the core of the spliceosome (58), could also regulate the HIV Gag
expression. Moreover, BUD13 from the RES complex and Tpr from the NPC, which were
reported to have a nuclear retention function, were tested as well by using two differ-
ent CRISPR/Cas sgRNAs targeting each of the genes. None of these targeting sgRNAs
tested induced BFP expression (Fig. S3B to D).
CRNKL1 and other cellular factors impact HIV-1 unspliced and fully spliced
mRNA levels. To follow up on the reduction of splicing as the potential mechanism of
enhanced Gag-BFP expression, the top 5 hits and WDR70 were analyzed for their effect
on HIV-1 mRNA splicing. Attempts to generate J-dual#3 cells with a stable knockout of
the six selected target genes were not successful, presumably due to the fact that the
selected genes are essential for cell viability (59). We therefore analyzed HIV RNA splic-
ing and nuclear export after knockdown of these genes in short-term cultures. J-
dual#3 cells were transduced with the lentiviral vectors encoding the different guide
RNA genes, and Gag-BFP-positive cells were sorted to enrich for cells with the desired
gene knockdown. Total RNA was then extracted from the sorted cells, and the copy
numbers of unspliced HIV RNA per ng extracted total RNA were determined and com-
pared to the copy numbers of unspliced RNA in J-dual#3 cells transduced with a nega-
tive control vector (NT1). Consistent with the stronger BFP expression, unspliced HIV
RNA copy numbers were also enhanced 3- to 9-fold (Fig. 4A). Fully spliced HIV-1 RNAs
FIG 3 Protein interaction network of confirmed screening hits. The 10 validated hits were analyzed by
the online database STRING for protein-protein interactions. The graph shows known and predicted
protein-protein interactions for the most enriched pathway, the “mRNA splicing” pathway (pathway
ID, GO 0000398; false discovery rate, 5.07e214; minimum required interaction score, 0.400 [medium
confidence]).
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FIG 4 Role of confirmed screening hits in HIV-1 RNA splicing and export. (A) J-dual#3 cells were
coinfected at an MOI of 3 with a lentiviral vector encoding Cas9 and a lentiviral vector expressing the
guide RNAs indicated. In addition, J-dual#3 cells were transduced by a lentiviral vector encoding GFP
or Rev at an MOI of 1. At 4 days after infection, BFP-positive cells were sorted by flow cytometry from
cells transduced with lentiviral vectors encoding Rev or the guide RNAs targeting the confirmed hits.
Matched controls expressing NT1 or GFP were used without sorting. Total RNA was purified from
whole-cell extracts. HIV-1 US and FS RNA copy numbers in these samples were quantified by RT-qPCR
and are shown as log copies per ng total RNA extracted from whole cells. Log copies from at least
three experiments, as well as their mean and standard error of the mean (SEM), are shown. The mean
of the FSwhole/USwhole ratio for each experiment is shown above the x axis for each of the treatment
groups. (B) J-dual#3 knockout cells and control cells were prepared as described for panel A, but total
RNA was extracted from the cytoplasmic fraction of each cell sample. Log copies per ng total
cytoplasmic RNA and mean FScyt./UScyt ratios. were calculated and presented as in panel A. (C) The
fold changes in the different treatment groups for the splicing efficacy (FSwhole/USwhole), the nuclear
(Continued on next page)
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were also quantified, revealing a marginal decrease in cells transduced with XAB2 and
WDR70 targeting sgRNAs but not with the other gene targeting sgRNA (Fig. 4A).
Differential effects of the gene targeting HIV-1 FS and HIV-1 US RNA also lead to
decreased ratios of FS to US transcripts (Fig. 4A). For comparative reasons, we also
transduced J-dual#3 cells in an independent experiment with a lentiviral vector
expressing Rev, sorted Gag-BFP-positive cells, and quantified HIV-1 US and FS tran-
scripts. Rev enhanced the US HIV-1 RNA levels approximately 5-fold, which coincided
with a minor reduction in FS transcripts (Fig. 4A).
The splicing process is closely linked to nuclear mRNA trafficking (60, 61). Therefore,
we also determined the effect of targeting the six selected candidate genes on the
cytoplasmic levels of HIV-1 US and FS RNA (Fig. 4B). Proper separation of the cytoplasm
from nuclear components was controlled by examining GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) pre-mRNA levels and a nuclear marker protein in the cyto-
plasmic fraction from Jurkat cells (62, 63). GAPDH pre-mRNA levels per ng total RNA
extracted from the cytoplasm were approximately 50-fold lower than GAPDH pre-
mRNA levels per ng total RNA extracted from whole cells. Consistently, the nuclear
LaminB protein could not be detected in the cytoplasmic fractions (Fig. S4).
After transduction with the different targeting vectors, HIV-1 US RNA in the cyto-
plasm of Gag-BFP-positive cells was enhanced approximately 22- to 116-fold, while the
cytoplasmic FS RNA levels were affected only 0.6- to 2.7-fold (Fig. 4B). The magnitude
of the enhancement of cytoplasmic levels of HIV-1 US RNA exceeded the enhancement
of HIV-1 US RNA in whole-cell extracts, indicating that knocking down the selected tar-
get genes not only reduced splicing but also enhanced nuclear export of the HIV-1 US
RNA. Strong enhancement of cytoplasmic HIV-1 US RNA export was also observed in
Rev-expressing cells. However, in contrast to the cells transduced with the targeting
vectors, cytoplasmic FS RNA levels in Rev-transduced cells were significantly reduced,
consistent with the previously reported suppression of the TAP/NXF1-mediated RNA
export by Rev (64).
To dissect the relative contributions of inhibition of splicing and enhancement of
nuclear export of HIV-1 US RNA, we compared the ratio of HIV-1 FS RNA to HIV-1 US
RNA in whole-cell extracts as a measure of splicing efficiency and the ratio of HIV-1 US
RNA in cytoplasmic extracts to the HIV-1 US RNA in whole-cell extracts as a measure of
nuclear export efficiency. This revealed two different patterns of responses. The fold
reduction in the splicing efficiencies in cells transduced with ISY1, XAB2, and WDR70
targeting vectors mirrored the fold enhancement of the respective nuclear export effi-
ciencies. Expression of Rev induced a similar pattern of response. In contrast, transduc-
tion with DHX38, BUD31, or CRNKL1 targeting vectors predominantly enhanced the
nuclear export efficiency with at least 3-fold-lower effects on splicing efficiency
(Fig. 4C). In particular, knockdown of CRNKL1 enhanced the ratio of HIV-1 US RNA in
cytoplasmic extracts to HIV-1 US RNA in total cell extracts more than 34-fold, while the
ratio of HIV-1 FS RNA to HIV-1 US RNA in whole-cell extracts was decreased only 4-fold.
Targeting of CRNKL1 also led to the strongest enhancement of cytoplasmic levels of
HIV-1 US RNAs without reducing cytoplasmic HIV-1 FS RNA levels (Fig. 4C), indicating
that CRNKL1 is a major nuclear retention factor of the genomic HIV-1 US RNA.
CRNKL1 associates with HIV-1 US RNA in the nucleus. As a nuclear retention fac-
tor of HIV-1 US RNA, CRNKL1 should either directly bind to the HIV-1 US RNA or be in
the same RNP complex. Due to lack of a putative RNA binding motif, it was suggested
FIG 4 Legend (Continued)
export efficacy (UScyt./USwhole), and cytoplasmic levels of unspliced (UScyt) and fully spliced (FScyt)
transcripts were calculated by dividing the values in the treatment groups by the ones obtained from
the matched control cells (NT1, GFP) as described in Materials and Methods. A paired t test was
performed on the log copy numbers/ng total RNA between each of the treatment groups and the
matched control. *, P, 0.05; **, P, 0.01; ***, P, 0.001. Unless otherwise indicated, differences were
not significant. Vertical dotted lines separate experiments that were not performed in parallel and
therefore contain independent controls. WDR70.KD cells were sorted on day 7 after transduction,
while other cells were sorted on day 4.
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that CRNKL1 binds to RNA via interactions with RNA binding proteins (65). However,
CRNKL1 also contains a half-a-tetratricopeptide repeat (HAT) motif that has been impli-
cated with direct RNA binding activity (66). To test whether CRNKL1 is indeed linked to
nuclear HIV-1 US RNA, the two major isoforms of CRNKL1 (100 and 83 kDa [67]) were
expressed in 293T cells with a myc tag. Pulldown experiments of nuclear extracts of
these cells with an anti-myc antibody and an isotype-matched control antibody con-
firmed specific immunoprecipitation of both isoforms (Fig. 5A). Precipitates of the small
and large isoforms of CRNKL1 also contained 34- and 23-fold higher levels of HIV-1 US
RNA (Fig. 5B), confirming that at least 1% to 2% of the nuclear HIV-1 US RNA is associ-
ated with CRNKL1. No interaction was observed between HIV-1 US RNA and an irrele-
vant myc-tagged protein, BirA, revealing the specificity of HIV-1 US RNA interaction
with CRNKL1. Comparable analyses for HIV FS RNA also revealed strong and specific
associations with both isoforms of CRNKL1 (Fig. 5C). Since CRNKL1 is a member of the
postcatalytic spliceosome (68), association of spliced transcripts with CRNKL1 com-
plexes is expected. The different effects of the CRNKL1 knockdown on cytoplasmic
RNA levels of HIV-1 US and FS RNA can therefore be best explained by the association
of CRNKL1 with two or more RNP complexes differing in function.
Knockdown of CRNKL1 enhances Gag expression in acutely infected 293T cells.
To exclude potential off-target effects of CRISPR/Cas-mediated genome editing,
CRNKL1 expression levels were also reduced by small interfering RNAs (siRNAs).
Cotransfection of 293T cells with a pool of four siRNAs targeting CRNKL1 and expression
plasmids encoding the large and short forms of CRNKL1 led to strongly reduced CRNKL1
expression levels (Fig. 6A), confirming the functionality of the siRNAs. A simple model to
test the effect of CRNKL1 knockdown on HIV-1 Gag expression might be to cotransfect
FIG 5 CRNKL1 proteins associate with HIV US RNA. (A) 293T cells transfected with expression plasmids
encoding the myc-tagged CRNKL1 or an irrelevant control protein (BirA) were infected with VSV-G-
pseudotyped HIV containing inactivating mutations in rev and env (HIV.r2e2). Nuclear fractions of these cells
were immunoprecipitated with beads coated with anti-myc antibody or an isotype-matched control antibody
(IgG2a). The precipitates were characterized by Western blot analysis with an anti-myc antibody. Dotted lines
indicate excision of irrelevant lanes from the Western blot image. The precipitates described in panel A were
also analyzed by RT-qPCR for HIV-US RNA and HIV-FS RNA levels. Results are expressed as percentages of
HIV-1 US RNA (B) and HIV-1 FS RNA (C) copy numbers in the precipitate relative to the copy numbers in the
nuclear fraction (input) prior to the immunoprecipitation. Fold changes of each replicate and mean fold
changes are indicated. The ratio paired t test was used for statistical analysis. L, CRNKL1 large isoform; S,
CRNKL1 small isoform.
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FIG 6 CRNKL1 knockdown increases expression of Gag after acute HIV infection. (A) Knockdown of CRNKL1 expression by siRNAs. CRNKL1-
targeting siRNAs (Si.) and nontargeting control siRNAs (Ctr.) were cotransfected with myc-tagged CRNKL1 expression plasmids to test their
efficacy and specificity. Exogenous CRNKL1 expression and endogenous a-tubulin expression in transfected 293T cells were monitored by
anti-myc and anti-a-tubulin Western blot analyses, respectively. (B) Effect of CRNKL1 knockdown on Gag-BFP expression in transiently
transfected cells. Targeting or nontargeting siRNAs were cotransfected with the HIV-dual-GT plasmid into 293T cells. Gag-BFP reporter
expression was monitored by FACS analysis. (C) Effect of CRNKL1 knockdown on Gag-BFP expression in stably transduced cells. 293T cells
stably transduced with HIV-dual-GT were transfected with the siRNAs and analyzed by flow cytometry. Shown are representative results
from one experiment (left panel) and the percentage of BFP1 DsRed1 cells plotted from three independent experiments (right panel). (D)
Effect of CRNKL1 knockdown on Gag expression in cells acutely infected with HIV-1. 293T cells were transfected twice within 4 days with
siRNAs and then infected with VSV-G-pseudotyped HIV-1 env mutants with (HIV.r2e2) or without (HIV.R1e2) inactivating mutations of Rev.
A reporter virus expressing wild-type Gag (HIV.r2e2DsRed) and a lentiviral vector expressing GFP from an internal promoter (pWPXL) were
also included. Gag, GFP, and a-tubulin expression was analyzed by Western blotting using antibodies targeting the proteins indicated. The
dotted line indicates excision of blank lanes from the Western blot image. (E) Effect of CRNKL1 knockdown on Gag expression in cells
acutely infected with HIV-1 by flow cytometry. 293T cells were infected with CRNKL1 targeting or nontargeting CRISPR lentivirus and VSV-
G-pseudotyped HIV.r2e2. Gag expression was analyzed on the single-cell level by intracellular staining for Gag and flow cytometry.
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these siRNAs targeting CRNKL1 with the HIV-dual-GT plasmid into 293T cells. However,
by doing this, we could not observe a rise in the Gag-BFP reporter protein expression
(Fig. 6B). In contrast, transfection of CRNKL1-targeting siRNAs into 293T cells stably trans-
duced with the same HIV-dual-GT reporter virus revealed an 11.6-fold increase in the per-
centage of transduced cells expressing Gag-BFP (Fig. 6C). Given the complex and
dynamic chromosomal architecture (69), the nuclear metabolism of mRNA expressed
from a circular plasmid can differ from mRNA expressed from a proviral DNA integrated
into a host chromosome. This may explain why the effect of CRNKL1 knockdown is de-
tectable in transduced but not transfected cells.
To further explore the effect of the CRNKL1 knockdown in acutely infected cells in
the presence and absence of Rev, 293T cells were first transfected with CRNKL1-target-
ing siRNAs or controls prior to infection with different VSV-G-pseudotyped HIV con-
structs. CRNKL1 knockdown enhanced Gag expression from HIV env mutants inde-
pendent of Rev (Fig. 6D, left panel). This enhancement was not due to an increased
susceptibility to virus infection after CRNKL1 siRNA treatment, since green fluorescent
protein (GFP) expression levels after transduction with a lentiviral vector encoding the
reporter gene from an internal promoter remained unchanged (Fig. 6D, right panel).
The magnitude of the enhancing effect of CRNKL1 knockdown by Western blot analy-
ses in infected 293T cells was lower than expected, based on the analyses of cytoplas-
mic RNA levels in transduced Jurkat cells enriched for CRNKL1 knockdown (Fig. 4B). As
the enhancing effect of the CRNKL1 knockdown may be masked by background
expression of Gag from cells expressing unreduced levels of CRNKL1, we also analyzed
Gag expression after CRNKL1 knockdown on the single-cell level by flow cytometry.
293T cells were transduced with lentiviral vectors targeting CRNKL1 or a control vector
and then infected with a VSV-G-pseudotyped HIV containing only inactivating muta-
tions in env and rev. Intracellular staining for Gag revealed a 4-fold increase in the per-
centage of Gag-positive cells after CRNKL1 knockdown (Fig. 6E), indicating that the
enhancing effect is not restricted to the HIV-dual-GT reporter virus or Jurkat cells.
CRNKL1 knockdown shifts cytoplasmic levels in HIV-1 splice variants. To con-
firm the role of CRNKL1 in the regulation of cytoplasmic HIV RNA levels and to explore
potential effects of CRNKL1 on cytoplasmic levels of cellular RNAs, a transcriptomic
analysis was performed after a short-term knockdown of CRNKL1. J-dual#3 reporter
cells were again transduced with the CRNKL1 targeting vector, and Gag-BFP-positive
cells were sorted by flow cytometry. RNA was extracted from the cytoplasmic fraction
of sorted cells and J-dual#3 cells transduced with a control vector. The extracted RNAs
from four biological replicates each were then enriched for mRNAs and sequenced by
the Illumina HiSeq procedure. In addition to this, cytoplasmic mRNA was extracted
from J-dual#3 cells expressing Gag-BFP after transduction with the Rev-encoding lenti-
viral vector and sequenced after mRNA enrichment.
To confirm the effectiveness of Cas9/sgRNA-mediated knockdown by transcrip-
tomic analysis, a core target region in exon 3 of the CRNKL1 gene was defined as nu-
cleotides (nt) 23 to 13 relative to the SpCas9 cleavage site. The number of transcrip-
tome sequencing (RNA-seq) reads that contained 10 nucleotides upstream and
downstream of the core target region were then determined (Fig. S5). While 55 reads
on average mapped to the region flanking the core target region in the control cells,
only a mean of 5.8 reads was detected in cells transduced with the CRNKL1 knockdown
vector (Fig. S5). Larger deletions and substitutions outside the core target region prob-
ably reduce the number of reads that can be mapped to the flanking region. A com-
parison of the reads from CRNKL1 knockdown cells that can be mapped to the flanking
region with the wild-type CRNKL1 core target region revealed insertions, deletions,
and point mutations in 22 out of 23 reads. In control cells, only 2 of 219 reads con-
tained single point mutations, clearly indicating efficient inhibition of CRNKL1 expres-
sion after Cas9/sgRNA targeting (Fig. S5).
HIV reads were mapped to the proviral DNA of HIV-dual-GT, revealing more reads
mapping to intronic regions after CRNKL1 knockdown and Rev expression than in the
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FIG 7 Effect of CRNKL1 depletion on HIV RNA splicing efficiency, accuracy, and export. (A) Alignments of reads from the transcriptomic
analysis to HIV-dual-GT. Shown are coverage profiles for the following individual RNA-seq samples, indicated by color (from top to bottom):
the nontargeting control (NT1, red), CRNKL1 knockdown (cyan), and rev overexpression (purple). Splice sites are shown in orange (donors)
and dark yellow (acceptors). Coding regions and long terminal repeats (LTRs) are indicated in dark blue. (B) Percentage of all HIV reads
among the total (HIV plus human) uniquely mapped reads. (C) Percentage of reads mapping to HIV exon 1 (from the transcription start site
to SD1) among the total uniquely mapped reads. (D) Percentage of reads in the first intron between SD1 and SA1 among the total uniquely
(Continued on next page)
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controls (Fig. 7A). The percentage of reads mapping to HIV among all the reads
uniquely mapping to either the human or the viral genome (total uniquely mapped
reads) was enhanced 2-fold in CRNKL1 knockdown cells (Fig. 7B). This was not due to
an enhanced transcriptional activity, since the percentage of reads mapping to exon 1,
which is shared by all HIV transcripts, was affected only marginally (Fig. 7C). Changes in
HIV-1 US RNA were assessed by determining the percentage of reads mapping to the
first intron of HIV-1 between splice donor 1 (SD1) and splice acceptor 1 (SA1) (Fig. 7D)
or mapping to the unspliced SD1 site (Fig. 7E), revealing 4- and 12-fold increases under
CRNKL1 knockdown conditions, respectively. The percentage of reads mapping to the
unspliced SD4 site and therefore containing the env intron also increased by a factor of
9 (Fig. 7F). The change in the percentage of all spliced HIV reads was negligible
(Fig. 7G), indicating that knockdown of CRNKL1 does not reduce splicing of HIV RNAs
in general.
To further explore differences in cytoplasmic levels of differentially spliced HIV-1
transcripts, the precise splice site usage was also systematically analyzed by calculating
the percentage of reads covering specific SD-SA pairs among all spliced HIV reads
(Fig. S6A and B). This revealed that knockdown of CRNKL1 reduced cytoplasmic HIV
transcripts spliced from SD1 to SA1 approximately 2-fold, while transcripts spliced
from SD1 to SA3 were enhanced 3-fold (Fig. 7H). To further assess the effect of the
CRNKL1 knockdown on the major Env-encoding transcript, the percentage of reads
spliced to SA5 was determined (Fig. 7I). Independent of the SD sites, usage of SA5
tended to be reduced, which is similar to an effect recently reported for the splicing
factor DDX17 (70). Moreover, the level of fully spliced transcripts seemed unaffected
by the CRNKL1 knockdown, since the percentages of reads spliced either from SD1 to
any splice acceptor site or from SD4 to SA7 were nearly the same (Fig. 7J).
CRNKL1 is a regulator of cytoplasmic cellular mRNA levels. The influence of the
CRNKL1 knockdown on cytoplasmic mRNA levels was also determined (Fig. S7A and B).
To display the results, the log2-transformed expression differences were plotted against
the expression level for each gene (Fig. 8A). To reduce noise and arbitrarily large fold
changes from low-expression genes, the log2 fold changes are shrunk, putting less
weight on low-expression genes. Significant differences after correction for multiple
testing revealed the upregulation of 1,249 and downregulation of 2,569 mRNAs,
respectively. Two hundred ten mRNAs even showed a more than 4-fold (log2 fold
change, .2) increase after knockdown of CRNKL1. Interestingly, upregulated mRNAs
were enriched for the functional categories involved in transcription (Fig. 8B) while
downregulated mRNAs were more frequently associated with functions in cell cycle
and organelle organization (Fig. 8B).
Given the close link between RNA export and splicing, a more general role of
CRNKL1 in cytoplasmic levels of splice variants was analyzed upon CRNKL1 knockdown.
Individual splicing events (including skipped exons, alternative splice sites, and
retained introns) were quantified using the percent spliced-in (PSI) metric (97), and dif-
ferential analysis was carried out by SUPPA (71). Of all quantified splicing events in
cytoplasmic mRNAs upon CRNKL1 depletion, 2.4% were upregulated and 1.6% were
downregulated (Fig. S7C and D). Similarly, alternative 39 and 59 splice sites were more
frequently detected upon CRNKL1 knockdown, suggesting that CRNKL1 inhibits usage
of alternative splice sites (Fig. 8C).
FIG 7 Legend (Continued)
mapped reads. (E) Percentage of reads across the unspliced SD1 site among the total uniquely mapped reads. (F) Percentage of reads across
the unspliced SD4 site among the total uniquely mapped reads. (G) Percentage of reads spanning SD and SA sites (spliced reads) among the
total uniquely mapped reads. (H) Percentages of reads spanning SD1 and the indicated splice acceptor sites among all spliced HIV reads. For
SD1-SA4abc, reads spliced from SD1 to SA4a, SA4b, and SA4c are summed up. (I) Percentages of reads spanning the indicated splice donor
sites and SA5 among all spliced HIV reads. (J) Percentage of reads spliced from SD1 to any SA site or from SD4 to SA7 among all spliced HIV
reads. (B to J) Shown are averages and standard deviations for the control and CRNKL1 knockdown samples. Individual values are shown as
black dots. For the rev overexpression sample (purple), the individual value is shown.
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A total of 295 introns were more frequently retained in cytoplasmic mRNAs after
CRNKL1 knockdown (Fig. 8C; Table S2). Further analyses revealed that not all introns of
the same transcript were affected in the same way (Fig. S8) but rather that intron
retention was highly specific for one or a few introns of the same gene. Enhanced cyto-
plasmic levels of intron-retaining mRNAs could be confirmed by real-time PCR using
total cytoplasmic RNAs extracted for RNA-seq and primers spanning the respective
exon-intron junctions (Fig. S8).
Genes containing introns or alternative splice sites that were upregulated after
CRNKL1 knockdown were not enriched for particular functional categories (data not
shown). Enhanced detection of introns or alternative splice sites in cytoplasmic mRNAs
after CRNKL1 knockdown indicate that CRNKL1 suppresses either these splicing events
or the nuclear export of the respective splice variants. To gain insight into the princi-
ples of regulation of these CRNKL1 knockdown-dependent introns and alternative
splice sites, we analyzed common features of these splicing events, including splice
FIG 8 Changes in the host transcriptome upon CRNKL1 knockdown (KD). (A) RNA-seq differential
expression analysis of mRNA abundance upon CRNKL1 KD. An MA plot shows differences in the
abundance of protein coding transcripts in CRNKL1 KD versus control (NT1) conditions. mRNAs with
significant differences are depicted in red (Padj , 0.1). (B) Gene Ontology enrichment analysis of
mRNAs with upregulated and downregulated expression upon CRNKL1 KD. The top enriched GO
Biological Process terms are shown. (C) Upregulated (included) (DPSI [KD2NT1] . 0.25, Padj , 0.01)
and downregulated (excluded) (DPSI [KD2NT1] , 20.25, Padj, 0.01) splicing events were quantified
from the RNA-seq CRNKL1 KD experiment. The bar plot shows absolute numbers of splicing events
that are up- or downregulated upon CRNKL1 knockdown. (D) Branch point scores were calculated by
BPfinder, and alternative 39 splice sites with higher usage in CRNKL1 KD condition were compared to
39 splice sites of the same genes with unchanged (constitutive) usage. Box plots and data points are
shown. The Wilcoxon rank sum test was used to test for significance. Absolute numbers of 39 splice
sites included in the analysis for each group are indicated. (E) Length of retained introns with higher
inclusion upon KD (CRNKL1 dependent) was compared to the length of unchanged introns upon KD
(CRNKL1 independent), which were located in the same transcripts as CRNKL1-dependent ones. Box
plots and data points are shown. The Wilcoxon rank sum test was used to test for significance.
Absolute numbers of retained introns analyzed in both groups are indicated. PSI, percent spliced-in
for splicing events.
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site strength, branch point and polypyrimidine tract score, GC content, and intron
length. CRNKL1 knockdown-dependent alternative 39 splice sites showed significantly
lower branch point scores than constitutive 39 splice sites (Fig. 8D) but a similar length
of polypyrimidine tracts (Fig. S7E). We also found that CRNKL1-dependent introns were
significantly longer than CRNKL1-independent introns within the same transcript
(Fig. 8E) and tended to have longer polypyrimidine tracts (Fig. S7F) but showed no dif-
ference in GC content (Fig. S7G).
DISCUSSION
Using a genome-wide screen for cellular factors repressing expression of an HIV-1
structural protein from the unspliced RNA, we identified 10 target proteins linked to
mRNA metabolism, with nine of them associated with the spliceosome. Interestingly,
five of them (ISY1, BUD31, XAB2, CRNKL1, and CWC22) are found in the Prp19-associ-
ated complex. This complex is important for stabilizing the spliceosome, which is also
involved in DNA repair, transcriptional elongation, and RNA export (57). Given that the
yeast homolog of WDR70 was reported to interact with Prp19 (72) and is now shown
to affect RNA splicing, it could be a new member of the Prp19-associated complex.
Due to the close linkage of splicing with RNA stability and nuclear RNA export, it is dif-
ficult to dissect the precise mechanism by which deletion of the identified nuclear pro-
teins enhance cytoplasmic RNA levels of HIV-1 US RNA.
Theoretically, enhanced transcription, reduced nuclear or cytoplasmic degradation,
decreased splicing, and/or enhanced nuclear export can increase cytoplasmic levels of
HIV-1 US RNA (UScyt) (Fig. 9). Enhanced transcription and decreased nuclear degrada-
tion seem unlikely, since the percentage of reads mapping to the first HIV-1 exon pres-
ent on all viral transcripts was not significantly enhanced (Fig. 7C). The absence of
enhanced cytoplasmic levels of FS RNAs and DsRed expression levels from the dual re-
porter construct (Fig. 4B; Fig. S2A) also argues against such a mechanism. Assuming a
single pool of nuclear HIV-1 US RNA that could follow either of the two remaining
pathways, differential effects on the nuclear export efficiency (UScyt./USwhole) and splic-
ing efficacy (FSwhole/USwhole) are expected (Fig. 9). Enhancing nuclear export of HIV-1 US
RNA should strongly enhance the UScyt./USwhole ratio. Since rapid export may reduce
FIG 9 Potential mechanisms leading to increased cytoplasmic levels of unspliced HIV-1 RNA.
Graphical representation of HIV-1 RNA metabolism and expected consequences of upregulation (:) or
downregulation (;) regulation or no change (!) of the respective steps on the nuclear export efficacy
(UScyt./USwhole) and splicing efficacy (FSwhole/USwhole). The nuclear export pathway is highlighted in bold.
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splicing and degradation, the FSwhole/USwhole ratio may decrease responsively, although
to a lower extent. Reduced splicing should primarily decrease the FSwhole/USwhole ratio
but not the UScyt./USwhole ratio (Fig. 9). Similar to an enhanced nuclear export, reduced
degradation of cytoplasmic HIV-1 US RNA should also lead to enhanced UScyt./USwhole
and decreased FSwhole/USwhole ratios (Fig. 9), but the association of the identified pro-
teins with the spliceosome localized in the nucleus argues against such a cytoplasmic
effector mechanism.
Clearly, ablation of all six target genes tested reduced the splicing efficacy (FSwhole/
USwhole), indicating that the targeted genes are enrolled in splicing and/or nuclear
retention. The relative contribution of reduced splicing versus enhanced nuclear export
of the HIV-1 US RNA differed between the different target genes. The XAB2 knockdown
decreased the splicing efficacy 12.5-fold and the nuclear export efficacy of the HIV-1
US RNA 11.7-fold. Since splicing and nuclear export efficacies were affected to a similar
degree, it is not possible to conclude whether XAB2 acts predominantly as a splicing or
a nuclear retention factor. This is consistent with previous observations that depletion
of splicing factors (e.g., SF1, U2AF65, and Prp19) can cause pre-mRNA leakage into the
cytoplasm (36, 73–75). In contrast to the effect of the XAB2 knockdown, the splicing ef-
ficacy after knockdown of CRNKL1 is decreased only 4.0-fold, while the nuclear export
efficiency based on the HIV-1 US RNA increases 34.6-fold. Since the ratio of HIV-1 FS to
US transcripts in the cytoplasmic RNA is also reduced to a larger extent than in the
whole-cell RNA, enhanced nuclear export of the HIV US RNA after inactivation of the
target gene seems to play a dominant role. This indicates that CRNKL1 is required pri-
marily for retention of the HIV-1 US RNA in the nucleus and not for its splicing. The pre-
cise molecular mechanism by which the CRNKL1 knockdown leads to a more than 100-
fold enhancement of cytoplasmic HIV US RNA levels remains to be further investigated.
Our observation that targeting of CRNKL1 did not enhance cytoplasmic levels of HIV-1
FS RNA, which uses the default TAP/NXF1 export pathway, indicates that CRNKL1 is
not a global nuclear mRNA retention factor. Our transcriptomic analysis also indicates
a highly selective differential regulation of cytoplasmic levels of HIV-1 splice variants.
The only spliced HIV-1 transcripts that were clearly upregulated by CRNKL1 knockdown
have spliced SD1 to the SA3 site (Fig. 7G) and may encode Tat. Whether this represents
an upregulation of env intron-retaining transcripts or the Tat-encoding fully spliced
transcript is unclear. The enhanced percentage of cytoplasmic HIV transcripts harbor-
ing an unspliced SD4 site (Fig. 7F) and the unchanged percentage of transcripts har-
boring a spliced SD4 site (Fig. 7J) argue for the former.
The transcriptomic analyses after CRNKL1 knockdown also revealed a selective reg-
ulation of cytoplasmic levels of a subset of cellular mRNAs. We found that 11.0% and
20.1% of expressed mRNAs in the cytoplasm were up- and downregulated, respec-
tively. Functionally, the upregulated mRNAs are associated with transcription, while
downregulated mRNAs are more frequently associated with the cell cycle and organ-
elle organization, suggesting that CRNKL1 participates as a master regulator in these
cellular programs. The large percentage of cellular genes affected by CRNKL1 knock-
down may be due not only to a direct consequence of reduced CRNKL1 levels but also
to secondary effects requiring further investigations. Depletion of an essential gene
such as the CRNKL1 gene may induce cell death. However, at the time of the analyses,
the pattern of forward and side scatters during flow cytometric analysis of BFP-positive
CRNKl1 knockout cells and BFP-negative cells were indistinguishable, while dead cells
clearly differed (data not shown). Consistently, the percentage of BFP-positive cells
remained unchanged for several days after the day of the analyses. In addition, the
transcriptomic pathway analyses did not provide any evidence for upregulation of
stress response genes or apoptosis-related genes.
Since altered nuclear export after CRNKL1 depletion could result in differences in
the abundance of different cytoplasmic mRNA isoforms, we investigated alternatively
spliced cytoplasmic isoforms upon CRNKL1 knockdown. Upon CRNKL1 depletion, a
much higher number of included introns and alternative 39 and 59 splice sites than the
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excluded ones were detected, suggesting that CRNKL1 promotes splicing of these
events or highly selective nuclear retention. Intron retention in the absence of CRNKL1
was highly restricted and even varied among introns of the same gene (see Fig. S8 in
the supplemental material). Searching for common properties of introns that were
retained revealed that their mean length was significantly greater than that of introns
with unchanged inclusion upon CRNKL1 depletion. In addition, usage of 39 splice sites
with lower branch point scores seems to be blocked in the presence of CRNKL1.
Therefore, the sequence features of CRNKL1-dependent splicing events seem to reside
at the 39 end rather than at the 59 end of the intron.
As a component of the core splicesome, CRNKL1 is well conserved from yeast to
human, is ubiquitously expressed in various tissues, and has been shown to affect
splicing reactions in vitro (53, 54, 67). Since CRNKL1 has a HAT motif composed of
alpha-helix pair repeats and belongs to the Prp19-associated complex, it has been
implicated primarily in DNA repair and cell cycle regulation (76, 77). Noticeably, this
motif may also confer direct RNA-binding activity. Beyond that, CRNKL1 has been
reported to be involved in RNA elongation and RNA export (78, 79). The role of
CRNKL1 in RNA extension and export is especially interesting, demonstrating that
CRNKL1 has interactions with the TREX exporting machinery at an early stage of RNA
synthesis, which might determine the “export” or “retain” status of an RNA.
Mechanistically, one plausible hypothesis based on the nuclear retention observed
for the HIV-1 unspliced RNA is that a nuclear RNP complex containing CRNKL1 binds to
RNA motifs present in a selective subset of cellular and viral introns, leading to their
nuclear retention and splicing. In support of this hypothesis, we observed that CRNKL1
is associated with nuclear HIV-1 unspliced RNA (Fig. 5C). The precise binding motif that
is bound by CRNKL1 or CRNKL1-containing RNP complexes needs to be further investi-
gated. Binding of CRNKL1-containing RNPs to binding motifs on cellular transcripts
leading to nuclear retention and degradation may also explain the increase in cytoplas-
mic levels of cellular mRNAs upon CRNKL1 knockdown. However, it is not possible to
exclude that changes in cellular mRNA levels are secondary effects of the CRNKL1
knockdown.
In summary, our study identifies three spliceosomal proteins that are required for
nuclear retention of the HIV-1 unspliced RNA and indicates that CRNKL1-dependent
nuclear retention is a novel mechanism for the regulation of cytoplasmic levels of
intron-retaining HIV-1 mRNAs that HIV-1 may have hijacked to regulate its complex
splicing pattern.
MATERIALS ANDMETHODS
Plasmids. Plasmids expressing viral proteins, HIV-1 Rev (pcRev), HIV-1 Tat (pcTat), HIV-1 codon-opti-
mized Gag-Pol (Hgpsyn), and VSV-G (pHiT-G), were described previously (27, 62). Lentiviral packaging
plasmid pPAX2 and pMD2.G were obtained from Addgene (no. 12260 and 12259). HIV-1 proviral plasmid
HIV.R1e2 is based on the HIV-1 molecular clone NL4-3 and contains a 4-nucleotide deletion at its NheI
site, leading to inactivation of env. The plasmid HIV.r2e2 contains an additional mutation of the start
codon of rev and a premature stop codon in the first rev exon (63). The plasmid HIV.r2e2 DsRed contains
the mutations that HIV.r2e2 has and is further mutated with nef by replacing it with DsRed as described
for HIV-dual-GT below. Lentiviral vector pWPXL delivering a GFP gene driven by an internal EF1a pro-
moter was obtained from Addgene (no. 12257). The Rev coding lentivector pWPXL-Rev was cloned by
replacing the GFP sequence between the MluI and EcoRI site in the pWPXL vector with the Rev coding
sequence from pcRev. The large isoform of myc-tagged CRNKL1 coding plasmid CRNKL1(L)-myc was
obtained from Origene (no. RC220334). The coding sequence of large CRNKL1 relative to amino acids
(aa) 1 to 169 was deleted from CRNKL1(L)-myc, generating the expression construct for small isoform
CRNKL1 [CRNKL1(S)-myc].
Proviral reporter plasmid HIV-dual-GT was constructed based on HIV.r2e2. A cassette containing
mTagBFP2, a PEST coding sequence (destabilized BFP), and two stop codons were ligated in frame to
the 39 end of gag, forming a new ORF for Gag-BFP. The slippery sequence TTTTTTA (nt 2085 to nt 2091
of GenBank entry AF324493.2) was mutated to CTTCCTG to prevent Gag-Pol translation (80). The coding
sequence of Nef close to its 5¨end (nt 8796 to nt 8880 of GenBank entry AF324493.2) was replaced by a
cassette consisting of a 3Ala linker sequence and the DsRed max coding region followed by two stop
codons. The sequence (nt 5131 to nt 6297 of GenBank entry AF324493.2) ranging from vif to vpu was
replaced by the corresponding region of NL4-3-D6-drEGFP (81) harboring inactivating point mutations
in vif, vpr, and vpu. The rev ORF was inactivated as described above for HIV.r2e2 by PCR mutagenesis.
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The plasmid HIV-dual-GT including the final sequence is available from AddGene (plasmid no. 122696).
Individual CRISPR knockout plasmids were constructed based on lentiCRISPRv2 (no. 52961; Addgene)
and GeCKO v2 sgRNA target sequences. All sgRNA sequences of the GeCKO v2 library can be found at
www.addgene.org/pooled-library/zhang-human-gecko-v2/. The different sgRNA sequences selected for
validation are provided in Table S1A in the supplemental material. Each of the sgRNA sequences was
cloned into the vector by following the instructions on the Addgene webpage (www.addgene.org/
52961/).
GeCKO v2 library. The pooled human GeCKO v2 CRISPR knockout plasmid library was a gift from
Feng Zhang (47) and was obtained from Addgene (no. 1000000048 and 1000000049). It is supplied as
two sublibraries, each containing three different sgRNA constructs targeting each gene in the genome.
Amplification of the lentiviral vector plasmid library was performed essentially as described by the con-
tributors’ protocol (47). The complexity of the library was confirmed by HiSeq NGS of the pooled plasmid
library (data not shown).
Cell culture. HEK293T (DSMZ) and TZM-bl (82) (NIH AIDS reagent program) cell lines were main-
tained in Dulbecco's Modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS)
and 1% penicillin/streptomycin (D10). Jurkat, clone E61 (ATCC), and reporter cell lines J-dual#3 and J-
dual#6 were maintained in Roswell Park Memorial Institute (RPMI) 1640 supplemented with 10% FCS
and 1% penicillin/streptomycin (R10). After expansion, J-dual#3 and J-dual#6 stocks were stored frozen
in aliquots at 280°C. A fresh aliquot was thawed and expanded in each assay.
Cell transfection. HEK293T cells were routinely transfected by the polyethylenimine (PEI) precipita-
tion method (62). In general, 3.5 million cells per T25 flask (CellStar) were seeded 24 h before transfec-
tion. For each transfection, plasmid DNA was mixed with calf thymus carrier DNA (Thermo Fisher
Scientific) to give a total of 10mg DNA. The 10mg DNA was mixed with 15ml PEI (1mg/ml; Sigma-
Aldrich) and added to the cells. After 8 h of incubation with the cells, the transfection medium was
replaced with fresh D10 medium. Supernatants or cells were harvested 48 h posttransfection. To pro-
duce pseudotyped HIV.R1e2, HIV.r2e2, HIV.r2e2DsRed, and HIV-dual-GT vector particles, 3mg proviral
plasmid, 3mg Hgpsyn, 2mg pHiT-G, 1mg pcTat, and 1mg pcRev were used. To produce individual CRISPR
knockout (CRISPR-KO) lentiviral vector particles, 5mg lentiCRISPRv2 plasmid, 3.75mg pPAX2, and 1.25mg
pMD2.G were used. To produce the pooled human GeCKO v2 lentiviral vector library, 24 million 293T
cells were seeded into a T175 tissue culture flask. At 24 h later, 20mg GeCKO v2 library plasmids, 15mg
pPAX2, 5mg pMD2.G, and 120ml GenJet transfection reagent (SignaGen) were used for transfection.
HIV-dual-GT-transduced Jurkat cells were transfected by the electroporation method described else-
where (83). In brief, 5.0 million stably transduced cells were electroporated with 50mg plasmids by the
Gene Pulser Xcell electroporation system (Bio-Rad) at 250 V and 1,500 mF. At 48 h posttransfection, cells
were harvested for flow cytometry analysis. The transfection efficiency after expression of a GFP reporter
plasmid was estimated to be between 10% and 20%.
siRNA transfection. A pool of four siRNA duplexes targeting CRNKL1 (Dharmacon; sequences shown
in Table S1E) or the control, siGENOME nontargeting siRNA control pool no. 2 (D-001206-14-50;
Dharmacon), was transfected into 293T or 293T reporter cells using the DharmaFECT 1 transfection rea-
gent (Dharmacon). For 2 105 cells, 10 pmol siRNA with or without 100 ng plasmid was transfected
essentially as described by the manufacturer. CRNKL1-myc expression by siRNA knockdown was exam-
ined by Western blotting at 2 days posttransfection; Gag-BFP expression influenced by CRNKL1 knock-
down was measured by fluorescence-activated cell sorting (FACS) at 4 days posttransfection. To enhance
the CRNKL1 knockdown efficiency, 4 105 cells were given two times 60 pmol siRNAs in 4 days and then
infected with VSV-G-pseudotyped HIV variants or a control lentivector at an MOI of 1. At 2 days postin-
fection, the cells were lysed using lysis buffer, whose volume was adjusted by cell number.
Western blot analyses. Immunoblotting for HIV-1 Gag/CA p24 was described previously (63).
Immunoblotting for Rev was performed with primary antibody sheep anti-Rev (1:4,500, no. H6006; US
Biological Life Sciences) and secondary antibody rabbit anti-goat Ig/HRP (1:5,000, no. P0160; Dako).
Immunoblotting for myc-tagged proteins and for GFP was performed using primary antibodies mono-
clonal mouse anti-myc tag (1:8,000, no. 2276; Cell Signaling Technology) and monoclonal mouse anti-
GFP (1:500, no. sc-9996; Santa Cruz) in combination with the secondary antibody goat anti-mouse IgG
(1:5,000, no. 115-035-146; Dianova). Immunoblotting for a-tubulin was performed using primary anti-
body polyclonal rabbit anti-a-tubulin antiserum (1:4,000, no. 600-401-880; Rockland), and secondary
swine anti-rabbit Ig/horseradish peroxidase (HRP) (1:5,000, no. P0217; Dako). In experiments shown in
Fig. 1B, 6A, and 6C, anti-a-tubulin blotting was conducted after stripping the blotted anti-CA and anti-
myc membranes with stripping buffer (no. 2504; Millipore). The membranes were then reblocked and
subsequently reblotted with antibodies as described above. Immunoblotting for LaminB was performed
with primary antibody goat anti-LaminB (C-20) (1:500, no. sc-6216; Santa Cruz Biotechnology) and sec-
ondary antibody rabbit anti-goat Ig/HRP (1:5,000, no. P0160; Dako).
Intracellular staining. 293T cells were transduced by the CRNKL1 targeting or nontargeting CRISPR
lentivectors at an MOI of 4. Two days later, the transduced cells were superinfected with VSV-G-pseudo-
typed HIV.r2e2 at an MOI of 1. For intracellular staining, 1.0 106 cells were fixed at 2 days postsuperin-
fection using 2% paraformaldehyde (PFA) (room temperature, 30min) and then permeabilized with
0.5% saponin in FACS buffer (room temperature, 10min). Cells were subsequently stained with 100ml
anti-p24 primary antibody (7 ng/ml in permeabilization buffer; 4°C, 1 h), followed by washing with 1ml
permeabilization buffer two times. Staining with secondary antibody was done with 100ml rat anti-
mouse IgG1/allophycocyanin (APC) conjugated (no. 17-4015-82; eBioscience) (1:500 dilution in perme-
abilization buffer; 4°C, 1 h), followed by washing two times.
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Lentiviral vector preparation, infection, and titration. Lentiviral vector particles were produced
by transfection of 293T cells with the plasmids mentioned above. HIV-1 proviruses were packaged with
a third-generation packaging system (Hgpsyn, pcRev, pcTat, and pHiT-G) (27, 84, 85). pWPXL, pWPXL-Rev,
CRISPR-KO constructs, and a pool of the two GeCKO v2 plasmid A and B sublibraries were packaged
with a second-generation packaging system (pPAX2 and pMD2.G) (48, 86) for higher infectious titers. At
48 h after transfection, the supernatants from transfected 293T cells were cleared and then filtered
through 0.45-mm filters. Viral stocks were aliquoted and stored under 280°C. Two batches of the GeCKO
v2 lentiviral vector library were prepared. HiSeq NGS analyses of sgRNA representation in cells trans-
duced with both batches showed an almost 100% identification of the sgRNAs encoded by the two
GeCKO v2 plasmid sublibraries.
Jurkat, J-dual#3, and J-dual#6 cells were infected with the lentiviral vectors or the lentiviral vector
library by spinoculation. A total of 1.5 million cells were infected with 1ml vector preparation, in the
presence of 8mg/ml Polybrene (Sigma-Aldrich), at 2,000 rpm, for 3 h, at 33°C. After spinoculation, the
supernatants were removed and the cells were continued to be cultured.
VSV-G-pseudotyped HIV.R1e2, HIV.r2e2, HIV.r2e2DsRed, and HIV-dual-GT vector particles were
titrated on TZM-bl cells as previously described (63). The titers were 5.8 106 and 5.1 106 TU/ml for
two independent titrations of HIV.R1e2, 4.3 106 and 5.7 106 TU/ml for two independent titrations of
HIV.r2e2, 6.1 106 and 5.4 106 TU/ml for two independent titrations of HIV.r2e2DsRed, and 6.4  105
and 5.0 105 TU/ml for two independent titrations of HIV-dual-GT. VSV-G-pseudotyped HIV-dual-GT vec-
tor particles were also titrated on Jurkat cells. The lentiviral reporter vector was serially diluted to 1:1,
1:2, 1:4, 1:8, and 1:16. The infection was done by the spinoculation method. At 48 h postinfection, cells
were analyzed by flow cytometry to determine the percentage of DsRed-positive cells in each dilution.
Vector titers on Jurkat cells were calculated as follows for all dilutions: (initial cell number)  (percentage
of DsRed-positive cells)  (dilution factor). The highest value resulting from these dilutions was taken as
the vector titer on Jurkat cells. The determined titers for two independent titrations of HIV-dual-GT were
4.9 105 and 6.9 105 TU/ml. The individual CRISPR-KO vectors and pWPLX-Rev, as well as the GeCKO
v2 lentiviral vector library, were titrated on J-dual reporter cells and parental Jurkat cells. The cells
infected by the serially diluted virus were grown for 24 h and then divided into two equal aliquots. One
aliquot was then cultured in 2mg/ml puromycin, the other without puromycin. After 30 h of growth, via-
ble cells were counted by trypan blue staining. The transduction percentage was calculated in the fol-
lowing way: [(number of living cells in treated population)  100]/(number of living cells in untreated
population). For the GeCKO v2 lentiviral vector library, the transduction percentage was multiplied by
the number of cells exposed to calculate the titer for the different dilutions of the library. The highest
value obtained from the different dilutions of the same batch of the lentiviral vector library was taken as
its titer. The titers were 1.3 107 TU/ml for the first batch and 2.2 106 TU/ml for the second batch.
Flow cytometry analysis and cell sorting. Flow cytometry analyses were done using the BDLSRII
flow cytometer (BD Biosciences). FACS data were analyzed by the FlowJo software. Cell sorting was
done on a MoFlo XDP (Beckman Coulter) at the FACS core facility of the medical faculty.
Next-generation sequencing of sgRNA libraries. Genomic DNA was extracted from the sorted or
control cells using either the Quick-DNA minikit or the Quick-DNA midi plus kit (Zymo Research). The
integrated lentiCRISPRv2 vector sgRNA sequences were amplified through three rounds of PCR using
the Taq DNA polymerase S (high specificity) (Genaxxon Bioscience). All obtained genomic DNA was used
as a template in parallel reactions in PCR1, with the following cycling conditions: 94°C for 2min, then 18
cycles of 95, 55, and 70°C for 15, 20, and 45 s, respectively, and a final extension at 70°C for 3min. PCR1
reaction mixtures of respective cell samples were then combined, and 10ml of the pooled PCR1 product
was used as a template in PCR2, consisting of 95°C for 2min, then 15 cycles of 95, 60, and 72°C for 15,
20, and 30 s, respectively, and a final extension at 72°C for 3min. In the indexing PCR3, 10 ng of purified
PCR2 product was subjected to 95°C for 2min, then 8 cycles of 95, 59, and 72°C for 15, 20, and 30 s,
respectively, and a final extension at 72°C for 3min. The primer sequences and primer combinations
used for each sample at each step are presented in Tables S1B and C. After PCR2 and PCR3, PCR prod-
ucts were purified by the AMPure XP PCR-cleanup kit (Beckman Coulter); DNA concentrations were
measured by the Qubit Quant-iT dsDNA HS assay kit (Thermo Fischer Scientific). Manipulations followed
the manufacturers’ instructions. DNA libraries were sequenced on Illumina MiSeq (for enriched samples)
or Ilumina HiSeq 2500 (for unselected control) instruments. NGS readouts were subjected to MAGeCK
analysis (49).
Cell fractionation, RNA isolation, and RNA quantification. The cell fractionation protocol has
been described previously (87). The plasma membrane was lysed with chilled NP-40 buffer consisting of
10mM HEPES (pH 7.8 adjusted by KOH), 10mM KCl, 20% glycerol, and 0.25% NP-40. Dithiothreitol (DTT)
was added to a final concentration of 1mM just before use. After incubation on ice for a maximum of 2
min, the supernatant consisting of the cytoplasmic fractions was collected after centrifugation at 400 
g, for 5min, at 4°C. Cytoplasmic RNA was extracted by the TRIzol (Thermo Fisher Scientific)-chloroform
(Sigma-Aldrich) method (88) or by the Direct-zol RNA miniprep plus kit (Zymo Research). RNA from the
whole-cell extracts was purified using the RNeasy kit (Qiagen). RNA extracted by TRIzol-chloroform or
the RNeasy kit was treated with DNase I (NEB) to remove DNA contamination. Under the protection of
5mM EDTA, DNase I was inactivated at 75°C for 10min. For the Direct-zol RNA miniprep plus kit-purified
RNA, DNA contamination was removed by the in-column DNA digestion reagents supplied. The total
RNA concentration was measured by the Qubit Quant-iT RNA HS assay kit (Thermo Fisher Scientific)
according to the manufacturer’s instructions.
Reverse transcription-PCRs (RT-qPCRs) for quantification of HIV-1 US and FS RNAs and cellular
GAPDH pre-mRNAs were done with the QuantiTect SYBR green RT-PCR kit (Qiagen) and performed
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essentially as described previously (62, 89). Using the Applied Biosystems 7500 real-time PCR machine,
cycling conditions were as follows: for HIV-1 US RNA, 95°C for 10 s for denaturation, 65°C for 60 s for
annealing, and 72°C for 30 s for elongation and fluorescence detection; for HIV-1 FS RNA, 95°C for 10 s
for denaturation, 64°C for 15 s for annealing, 72°C for 15 s for elongation, and 81°C for 30 s for fluores-
cence detection.
RT-qPCRs for relative quantification of intron 6-retaining RPL10 mRNAs and intron 1-retaining
C19orf53 mRNAs were done with primers given in Table S1D. Cycling conditions for both were as fol-
lows: 95°C for 10 s for denaturation, 50°C for 60 s for annealing, and 72°C for 60 s for elongation and fluo-
rescence detection.
Calculation of the ratios of HIV FS to US RNA levels and fold changes. To measure the effect of
candidate genes and Rev on RNA splicing efficacy, we first determined the ratio of FSwhole to USwhole by
dividing the FS copy numbers/ng extracted RNA by the US copy numbers/ng extracted RNA for each
sample of each treatment group (knockdown or 1Rev) and then calculated the mean of the ratios of
replicates of each treatment group. The mean of the ratios of each treatment group was then divided by
the mean of the ratios observed in matched control cells transduced with the NT1 or the GFP expression
vector to calculate the fold changes given in Fig. 4C.
To measure the effect of candidate genes and Rev on the nuclear export efficacy (41) for HIV-1 US
RNA for each treatment group, the mean US copy numbers/ng RNA extracted from the replicates of the
cytoplasmic fractions were divided by the mean US copy numbers/ng RNA extracted from replicates of
the whole-cell lysates. The ratio of each treatment group was then again divided by the ratio observed
in controls cells transduced with the NT1 or the GFP expression vector to calculate the fold changes
given in Fig. 4C.
Fold changes for cytoplasmic levels of US or FS RNA were calculated by dividing the mean US or FS
copy numbers per ng of extracted RNA of each treatment group by the mean derived from the control
groups.
RNA immunoprecipitation. Nuclear fractions from 2 107 transfected and infected 293T cells were
lysed by 600ml of prechilled NP-40 lysis buffer (50mM HEPES-KOH at pH 7.4, 150mM KCl, 2mM EDTA,
0.5% [vol/vol] NP-40, 0.5mM DTT, Roche complete EDTA-free protease inhibitor cocktail, 40 U/ml
Promega RNasin RNase inhibitor) while incubated on ice for 5min. Lysates were cleared by centrifuga-
tion (16,000 relative centrifugal force [RCF], 4°C, 15min). A 200-ml aliquot of the supernatant was used
to quantify the amount of input RNA. Another 200-ml aliquot of the supernatant was incubated with
20ml protein G Dynabeads (Invitrogen) precoated with 1mg of anti-myc tag antibody or the same
amount of an IgG2a isotype control antibody (Southern Biotech) respectively. RNP binding was per-
formed overnight at 4°C. Washing was done with prechilled immunoprecipitation (IP) wash buffer
(50mM HEPES-KOH at pH 7.4, 150mM KCl, 2mM EDTA, 0.05% [vol/vol] NP-40, 0.5mM DTT, complete
EDTA-free protease inhibitor cocktail, 40 U/ml Promega RNasin RNase inhibitor) for six times with the aid
of a magnetic rack (Invitrogen). Proteins bound to the beads were recovered from 10% of the beads by
heat denaturation and characterized by Western blot analyses. RNA associated with the remaining 90%
of the beads was purified by the TRIzol method. Input RNA and bead-associated RNA were analyzed by
RT-qPCR.
RNA-seq. Cytoplasmic RNAs were extracted from the sorted BFP-positive or unsorted control J-
dual#3 cells with the Direct-zol RNA miniprep plus kit. RNA qualities were controlled by the 2100
Bioanalyzer instrument (Agilent) (data not shown). Poly(A)-containing RNAs were enriched, fragmented,
and reverse transcribed using the Illumina TruSeq stranded mRNA kit. Work flows for generating DNA
libraries from each sample were performed essentially as described by the Illumina standard protocol
(https://support.illumina.com/downloads/truseq-stranded-mrna-reference-guide-1000000040498.html). The
libraries were sequenced on an Illumina HiSeq 2500 platform, and the reads were saved together with a
quality score. Raw data were converted to reads including a quality score by Software bcl2fastq v2.17.
Sequences matching Illumina TruSeq adapters were masked. Low-quality bases, poly(A) or poly(T)
stretches, and masked bases were trimmed by Software fqtrim v0.9.5. Read quality was checked after
sequencing and after base trimming by Software fastqc v0.11.8. For the viral genome, reads were aligned
to HIV-dual-GT using hisat2 (90). Read counting for the different features was performed using samtools
(91) and regtools (92).
For splicing and differential expression analysis, reads were aligned to the human transcriptome
using RSEM v1.2.20 (93) and Bowtie v1.1.2 (93) as the read alignment program using default parameters.
Differential expression analysis was performed by DESeq2 v1.18.1 (93) using the RSEM output for read
counts per gene. We considered genes that showed an absolute log2-transformed fold change greater
than 1 and an adjusted P value (Padj) of less than 0.1 as differentially expressed. To exclude low-expres-
sion genes, we considered only those with a mean number of transcripts per kilobase million (TPM)
greater than 1 in either untreated or knockdown samples. Gencode v19 annotation was used in all steps
of the analysis, including in the definition of protein coding genes. The read mapping profiles were
exhibited via the Integrative Genomics Viewer (IGV) v2.3 (94). Differential splicing analysis was per-
formed with SUPPA (71) using TPM values from the RSEM transcript isoform output. For PSI calculation,
events were required to pass the expression filter of TPM greater than 1 (-f 1 parameter). We considered
splicing events with Padj values lower than 0.01 and absolute DPSI values greater than 0.25 as differen-
tially included or excluded. Polypyrimidine track length and branch point scores were calculated using
BPfinder (95). Splice site strength was calculated using MaxENT (96) (https://hollywood.mit.edu/
burgelab/software.html).
Data availability. The raw and processed data of RNA-seq are accessible via GEO (Gene Expression
Omnibus) accession number GSE144347.
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